Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
EIF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TRAM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CNOT8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CUL7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KCNQ4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPTLC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBASH3B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TICRR - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZXDC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MAGOHB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
SEPT8 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PLK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OR4F29 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CNOT9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TAF4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CNOT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DPYD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on